DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Gilead Sciences, Inc. (GILD)
« Back to company indexGILD Chatter Timeline
Stock Ticker for GILD
Most Active Tweeters for GILD
| User | Tweets |
|---|---|
| @Gambiste1 | 33 |
| @OphirGottlieb | 8 |
| @moon_shine15 | 8 |
| @Tickeron | 7 |
| @1MinuteStock | 7 |
Recent Tweets for GILD
 |
@BioAnalysisCent $GILD $ARVN Biotech Analysis Central "Gilead's Latest Bolt-On Buys Point To A New Way Of Approaching Drug Developme… https://t.co/fJ6E20igbg June 26th 2019, 8:06pm |
 |
@Nateballamolly $gild will likely make a couple acquisitions by year end...my guess is in NASH space and cancer June 26th 2019, 7:06pm |
 |
@Gambiste1 RT @moon_shine15: $GILD - am a buyer of this major weekly breakout backtest $67 https://t.co/zvpHzuJU0h June 26th 2019, 6:06pm |
|
@Gambiste1 RT @moon_shine15: $GILD buys immediately onside today. Wake me when over $70. June 26th 2019, 6:06pm |
 |
@1MinuteStock Wondering about #sentiment indicator for $GILD? The Short Ratio is 1.9% https://t.co/aGOMONHc1U June 26th 2019, 4:06pm |
 |
@moon_shine15 Wait until they start upgrading $GILD ? be patient June 26th 2019, 2:06pm |
 |
@SickEconomics Smart partnership: $GILD pays mostly for performance.... Seeking Alpha: Gilead's Latest Bolt-On Buys Point To A Ne… https://t.co/UHqqORCWPA June 26th 2019, 12:06pm |
 |
@SwingTradeBot Recent $GILD technical alerts: Slingshot Bullish plus 2 more alerts... https://t.co/DTxahYN57c June 26th 2019, 12:06pm |
|
@moon_shine15 $GILD forceful bounce off the generational buy spot. Go figure. June 26th 2019, 12:06pm |
|
@moon_shine15 $GILD buys immediately onside today. Wake me when over $70. June 26th 2019, 11:06am |
 |
@newswelldone $GILD: Louisiana Launches Hepatitis C Innovative Payment Model With …: https://t.co/HhaYris4YW June 26th 2019, 11:06am |
 |
@CMLviz RT @OphirGottlieb: $GILD Buy The Dip Trigger and Momentum https://t.co/oGVGhC9PsF - Just took an 82% profit from June 13 - June 21. June 26th 2019, 11:06am |
 |
@Allstocknews $GILD Louisiana Launches Hepatitis C Innovative Payment Model With Asegua Therapeutics, Aiming to Eliminate t From our Stock News Alerts App June 26th 2019, 11:06am |
 |
@OphirGottlieb $GILD Buy The Dip Trigger and Momentum https://t.co/oGVGhC9PsF - Just took an 82% profit from June 13 - June 21. June 26th 2019, 11:06am |
 |
@alexserri1 $GILD - Louisiana Launches Hepatitis C Innovative Payment Model With Asegua Therapeutics, Aiming to Eliminate https://t.co/GEfVb0rmV6 June 26th 2019, 11:06am |
|
@moon_shine15 July last month to buy $GILD under $70 for next few years at least. Bold claim , i know. June 26th 2019, 11:06am |
|
@moon_shine15 $GILD - am a buyer of this major weekly breakout backtest $67 https://t.co/zvpHzuJU0h June 26th 2019, 10:06am |
|
@moon_shine15 Backtest of weekly/monthly breakout spot - this is the Best Buy position for $gild in several years June 26th 2019, 9:06am |
 |
@XOsignals $GILD dont need to be genius to know 80$ this year https://t.co/7K1MyIbYjl so what you are waiting for?!!! June 26th 2019, 9:06am |
|
@1MinuteStock We calculated 63-day Expected Return of $GILD for you: 8.11% https://t.co/mTgAzTSiLD June 26th 2019, 4:06am |
|
@1MinuteStock We calculated 21-day Expected Return of $GILD for you: 3.77% https://t.co/mTgAzTSiLD June 26th 2019, 2:06am |
 |
@SayYayToDrugs All-you-can-eat Epclusa buffet from $GILD. https://t.co/OxEY1mCiVE June 26th 2019, 12:06am |
 |
@SeekingAlpha $GILD - Gilead's Latest Bolt-On Buys Point To A New Way Of Approaching Drug Development https://t.co/6FBz7B9Q2m June 26th 2019, 12:06am |
 |
@optioncharts $GILD Max Pain=67.00. Maturity=06/28/2019. #maxpain #options https://t.co/SbdFHQtoNj https://t.co/Yd5XbVWajN June 25th 2019, 10:06pm |
 |
@MC_OptionTrades $GILD I.V. in the ATM 16-Aug-19 Climbs +3.1% to 25.9. Options Imply a Move of ±7.9% with 52 Days to Exp https://t.co/ZQOfhHMvOD June 25th 2019, 9:06pm |
 |
@BioCentury Gilead to add lipid kinase inhibitors to pipeline via Carna deal $GILD https://t.co/do4S9iEvsA June 25th 2019, 6:06pm |
|
@MC_OptionTrades $GILD Gilead Sciences Inc. Option Order Flow Sentiment is 58.1% Bullish. https://t.co/sD9L6tOUzF June 25th 2019, 4:06pm |
|
@Gambiste1 RT @Debra_Stotler: $GILD Next stop 72. https://t.co/ambWzrf481 June 25th 2019, 12:06pm |
|
@Gambiste1 RT @KymLang: $GILD very nice room to 70.50 June 25th 2019, 12:06pm |
 |
@newswithvalue $JNJ $GILD: The 10 Biggest Biotech Stocks: https://t.co/VtEoOCwIEP June 25th 2019, 11:06am |
 |
@Debra_Stotler $GILD Next stop 72. https://t.co/ambWzrf481 June 25th 2019, 10:06am |
|
@Gambiste1 RT @wisdominvestors: $GILD a great addd waiting for my target. Contemplating holding but hey gotta lock shit in June 25th 2019, 10:06am |
|
@Gambiste1 RT @syinvesting: $GILD announces license agreement with Carna Biosciences for the development of small molecule compounds in immuno-oncolog… June 25th 2019, 10:06am |
|
@Gambiste1 RT @CHItraders: $GILD Gilead inks deal with Carna Bio for immuno-oncology therapies https://t.co/aUOTkG76Y7 June 25th 2019, 10:06am |
|
@Gambiste1 RT @MarketCurrents: $GILD - Gilead inks deal with Carna Bio for immuno-oncology therapies https://t.co/2XQs9G2fyy June 25th 2019, 10:06am |
|
@Gambiste1 RT @fwpharma: Gilead enters deal with Carna Biosciences to develop small-molecule drugs in immuno-oncology https://t.co/UVI84KGqLF $GILD June 25th 2019, 10:06am |
|
@Gambiste1 RT @TeamDayTrader: $GILD is also on my radar like flies on shit. Again, I'm looking long, I like the consolidation period & if this market… June 25th 2019, 10:06am |
 |
@KymLang $GILD very nice room to 70.50 June 25th 2019, 10:06am |
 |
@wisdominvestors $GILD a great addd waiting for my target. Contemplating holding but hey gotta lock shit in June 25th 2019, 9:06am |
 |
@syinvesting $GILD announces license agreement with Carna Biosciences for the development of small molecule compounds in immuno-… https://t.co/lqnm8Z9Gnb June 25th 2019, 9:06am |
 |
@CHItraders $GILD Gilead inks deal with Carna Bio for immuno-oncology therapies https://t.co/aUOTkG76Y7 June 25th 2019, 6:06am |
 |
@MarketCurrents $GILD - Gilead inks deal with Carna Bio for immuno-oncology therapies https://t.co/2XQs9G2fyy June 25th 2019, 6:06am |
 |
@fwpharma Gilead enters deal with Carna Biosciences to develop small-molecule drugs in immuno-oncology https://t.co/UVI84KGqLF $GILD June 25th 2019, 5:06am |
 |
@ThisLincolnian Financial Comparison: Audentes Therapeutics $BOLD & Gilead Sciences $GILD https://t.co/hU3i9Mg2ap June 25th 2019, 4:06am |
 |
@WeekHerald Audentes Therapeutics $BOLD vs. Gilead Sciences $GILD Head to Head Comparison https://t.co/qRjUBxCNmg June 25th 2019, 4:06am |
 |
@TeamDayTrader $GILD is also on my radar like flies on shit. Again, I'm looking long, I like the consolidation period & if this ma… https://t.co/cMcqpmRffq June 24th 2019, 8:06pm |
|
@newswelldone $GILD: Gilead and Carna Biosciences Announce Research and …: https://t.co/GqJ7V5NDMw June 24th 2019, 7:06pm |
 |
@portefeuillefun $GILD. https://t.co/QQYQW0bdkR June 24th 2019, 7:06pm |
|
@Allstocknews $GILD Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-On From our Stock News Alerts App June 24th 2019, 7:06pm |
|
@alexserri1 $GILD - Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel https://t.co/9sqmIy1vLT June 24th 2019, 7:06pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.